2014
Addressing the problem of ADHD medication as neuroenhancements
Graf W, Miller G, Nagel S. Addressing the problem of ADHD medication as neuroenhancements. Expert Review Of Neurotherapeutics 2014, 14: 569-581. PMID: 24738763, DOI: 10.1586/14737175.2014.908707.Peer-Reviewed Original ResearchConceptsADHD medicationNeurological disordersAttention deficit hyperactivity disorder (ADHD) diagnosisMedication overusePotent medicationsHealthy personsSubstance diversionMedicationsDisorder diagnosisNonmedical purposesDisordersIllegal diversionADHDOngoing scrutinyDiversionMethylphenidatePrevalenceDiagnosisPersonsAmphetamine
2007
Myelination as Assessed by Conventional MR Imaging is Normal in Young Children with Idiopathic Developmental Delay
Maricich SM, Azizi P, Jones JY, Morriss MC, Hunter JV, Smith EO, Miller G. Myelination as Assessed by Conventional MR Imaging is Normal in Young Children with Idiopathic Developmental Delay. American Journal Of Neuroradiology 2007, 28: 1602-1605. PMID: 17846220, PMCID: PMC8134387, DOI: 10.3174/ajnr.a0602.Peer-Reviewed Original ResearchConceptsSubcortical U-fibersExtent of myelinationDevelopmental quotientBrain MRU-fibersWhite matterBrain regionsSubcortical myelinationIDD groupConventional brain MRBasis of historyYoung childrenConventional MR imagingMyelination scoreClinical historyPediatric neuroradiologistsIntracranial lesionsParietal lobeAxial T2Idiopathic developmental delayPsychomotor retardationScoring systemClear causePsychometric testingMyelination